AAAAAA

   
Results: 1-4 |
Results: 4
ZOLMITRIPTAN, A 5-HT1B 1D RECEPTOR AGONIST FOR THE ACUTE ORAL TREATMENT OF MIGRAINE - A MULTICENTER, DOSE-RANGE FINDING STUDY/
Authors: DAHLOF C DIENER HC GOADSBY PJ MASSIOU H OLESEN J SCHOENEN J WILKINSON M SWEET RM KLEIN KB
Citation: C. Dahlof et al., ZOLMITRIPTAN, A 5-HT1B 1D RECEPTOR AGONIST FOR THE ACUTE ORAL TREATMENT OF MIGRAINE - A MULTICENTER, DOSE-RANGE FINDING STUDY/, European journal of neurology, 5(6), 1998, pp. 535-543
SUMMARY OF THE EFFICACY OF 311C90 - A NEW ACUTE TREATMENT FOR MIGRAINE
Authors: KLEIN KB
Citation: Kb. Klein, SUMMARY OF THE EFFICACY OF 311C90 - A NEW ACUTE TREATMENT FOR MIGRAINE, Annals of neurology, 40(3), 1996, pp. 65-65
311C90, A NEW CENTRAL AND PERIPHERALLY ACTING 5-HT1D RECEPTOR AGONISTIN THE ACUTE ORAL TREATMENT OF MIGRAINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGE FINDING STUDY
Authors: VISSER WH KLEIN KB COX RC JONES D FERRARI MD
Citation: Wh. Visser et al., 311C90, A NEW CENTRAL AND PERIPHERALLY ACTING 5-HT1D RECEPTOR AGONISTIN THE ACUTE ORAL TREATMENT OF MIGRAINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGE FINDING STUDY, Neurology, 46(2), 1996, pp. 522-526
EMERGING PRECLINICAL AND CLINICAL PROFILE OF 311C90 - A POSTER REVIEWAND DISCUSSION
Authors: FERRARI MD MARTIN GR EARL NL KLEIN KB
Citation: Md. Ferrari et al., EMERGING PRECLINICAL AND CLINICAL PROFILE OF 311C90 - A POSTER REVIEWAND DISCUSSION, European neurology, 36, 1996, pp. 19-23
Risultati: 1-4 |